Third Harmonic Bio, Inc. THRD
Institutional shares held
5.9 Million
0
calls
0
puts
Total value of holdings
$31.7M
$0
calls
$0
puts
Market Cap
$217M
40,328,900
Shares Out.
Institutional ownership
14.62%
# of Institutions
22
We take great care to ensure that the data presented and summarized in this overview for Third Harmonic Bio, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding THRD
View all-
Bml Capital Management, LLC Zionsville, IN3.82MShares$20.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.43MShares$7.68 Million0.0% of portfolio
-
Jbf Capital, Inc. Aspen, CO250KShares$1.35 Million0.2% of portfolio
-
Fny Investment Advisers, LLC100KShares$538,5380.23% of portfolio
-
Dimensional Fund Advisors LP Austin, TX93.9KShares$505,3910.0% of portfolio
-
Cantor Fitzgerald, L. P. New York, NY86.3KShares$464,4280.01% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL37.2KShares$200,3830.0% of portfolio
-
Nuveen, LLC Charlotte, NC28KShares$150,4400.0% of portfolio
-
Rhumbline Advisers Boston, MA20.7KShares$111,4030.0% of portfolio
-
Met Life Investment Management, LLC Whippany, NJ16.9KShares$90,7010.0% of portfolio
Latest Institutional Activity in THRD
Top Purchases
Top Sells
About THRD
Insider Transactions at THRD
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2025
|
Natalie C. Holles CEO |
SELL
Other acquisition or disposition
|
Direct |
1,218,836
-100.0%
|
-
|
|
Aug 11
2025
|
Hans Martin Seidel |
SELL
Other acquisition or disposition
|
Direct |
85,753
-100.0%
|
-
|
|
Aug 11
2025
|
Mark T Iwicki |
SELL
Other acquisition or disposition
|
Direct |
128,631
-100.0%
|
-
|
|
Aug 11
2025
|
David P Bonita |
SELL
Other acquisition or disposition
|
Direct |
5,779,071
-100.0%
|
-
|
|
Nov 08
2024
|
Edward R. Conner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,117
-100.0%
|
$31,755
$15.0 P/Share
|
|
Nov 08
2024
|
Edward R. Conner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,117
+50.0%
|
$8,468
$4.2 P/Share
|
|
Nov 01
2024
|
Atlas Venture Fund Xi, L.P. |
SELL
Other acquisition or disposition
|
Direct |
515,688
-5.0%
|
-
|
|
Oct 29
2024
|
Bvf Partners L P |
SELL
Open market or private sale
|
Direct |
1,000,000
-24.12%
|
$14,000,000
$14.3 P/Share
|
|
Oct 28
2024
|
Edward R. Conner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,673
-100.0%
|
$40,095
$15.0 P/Share
|
|
Oct 28
2024
|
Edward R. Conner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,673
+50.0%
|
$10,692
$4.2 P/Share
|
|
Sep 19
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,497
-100.0%
|
$132,958
$14.29 P/Share
|
|
Sep 19
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
SELL
Exercise of conversion of derivative security
|
Direct |
9,497
-50.0%
|
$37,988
$4.2 P/Share
|
|
Sep 19
2024
|
Edward R. Conner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,790
-100.0%
|
$71,850
$15.0 P/Share
|
|
Sep 19
2024
|
Edward R. Conner Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,790
+50.0%
|
$19,160
$4.2 P/Share
|
|
Sep 18
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
SELL
Open market or private sale
|
Direct |
503
-100.0%
|
$7,042
$14.0 P/Share
|
|
Sep 18
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
503
+50.0%
|
$2,012
$4.2 P/Share
|
|
Jun 26
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$120,000
$12.46 P/Share
|
|
Jun 26
2024
|
Julie Person CHIEF ADMINISTRATIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$40,000
$4.2 P/Share
|
|
Jun 07
2024
|
Jennifer Dittman Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
494
-100.0%
|
$6,916
$14.17 P/Share
|
|
Jun 07
2024
|
Jennifer Dittman Chief Operating Officer |
SELL
Grant, award, or other acquisition
|
Direct |
494
-50.0%
|
$1,976
$4.2 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
7.21M
Shares
From
4
Insiders
| Other acquisition or disposition | 7.21M shares |
|---|